[1]
Pridmore, W. 2021. Updates from the fray: rational off-label and over-the-counter prescribing in amyotrophic lateral sclerosis. RRNMF Neuromuscular Journal. 2, 1 (Feb. 2021), 36–40. DOI:https://doi.org/10.17161/rrnmf.v2i1.14789.